Anti-Human TGFB2 Recombinant Antibody

Name: Anti-Human TGFB2 Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1117

YR1117

科研级 Lerdelimumab ( 乐德木单抗 ), Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab

DATASHEET MSDS

Product Description

Alias	科研级 Lerdelimumab ( 乐德木单抗 ), Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab
Catalog Number	YR1117
Molecular Name	Lerdelimumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4
Formulation	PBS, pH7.5
Background	Lerdelimumab (CAT-152, intended trade name Trabio) is a human monoclonal antibody and an immunosuppressive drug targeting TGF beta 2. It was being developed to reduce scarring after glaucoma drainage surgery. Development was stopped in late 2005 after unsuccessful trial results for that condition.
CAS Number	285985-06-0
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	TGFB2[Homo sapiens]

Login